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Abstract.  The pancreatic B cell has been used as a 
model to compare the release of newly synthesized 
prohormone/hormone  with that of stored hormone. 
Secretion of newly synthesized proinsulin/insulin  (la- 
beled with [3H]leucine during a  5-min pulse) and 
stored total immunoreactive insulin was monitored 
from isolated rat pancreatic islets at basal and stimula- 
tory glucose concentrations over 180 min.  By 180 min, 
15 % of the islet content of stored insulin was released 
at  16.7 mM glucose compared with 2 % at 2.8 mM 
glucose. After a  30-min lag period, release of newly 
synthesized (labeled) proinsulin and insulin was de- 
tected; from 60 min onwards this release was stimu- 
lated up to  ll-fold by 16.7 mM glucose. At  180 min, 
60 % of the initial  islet content of labeled proinsulin 
was released at  16.7 mM glucose and 6% at 2.8 mM 
glucose. Specific radioactivity of the released newly 
synthesized hormone relative to that of material  in is- 
lets indicated its preferential release.  A  similar degree 
of isotopic enrichment of released,  labeled products 
was observed at both glucose concentrations.  Quantita- 
tive HPLC analysis of labeled products indicated that 
(a) glucose had no effect on intracellular  proinsulin to 
insulin conversion; (b) release of both newly synthe- 
sized proinsulin and insulin was sensitive to glucose 
stimulation;  (c) 90%  of the newly synthesized hor- 
mone was released as insulin;  and (d) only 0.5%  of 
proinsulin was rapidly released (between 30 and 60 
min)  in a glucose-independent fashion.  It is thus con- 
cluded that the major portion of released hormone, 
whether old or new,  processed or unprocessed,  is 
directed through the regulated pathway,  and therefore 
the small (<1%) amount released via a constitutive 
pathway cannot explain the preferential release of 
newly formed products from the B cell. 
T 
HE general outline for the sequence of steps involved 
in  the biosynthesis,  processing,  packaging,  storage, 
and release of secretory products (including polypep- 
tide hormones) has been known for many years (31, 33). The 
final step in this sequence is the extrusion of secretory gran- 
ule contents  by exocytosis.  It has often been reported that 
there  is  preferential  release of newly synthesized  product 
over that which is stored intracellularly.  This observation has 
been made for a variety of secretory products including insu- 
lin (6,  11, 22, 38), placental  lactogen  (43, 47), parathyroid 
hormone (26), alkaline phosphatase  (4), pancreatic  amylase 
(39),  prolactin  (35,  44),  vasopressin  (36),  gonadotrophin 
(20), and also for some neurotransmitters,  including acetyl- 
choline (46),  brain catecholamines  (34),  and serotonin  (3). 
Within  a given secretory cell type the total  population of 
secretory granules will consist of a mixture of newly formed 
and older stored granules.  Preferential  release of a newly 
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synthesized product indicates  that instead of random secre- 
tion of these two granule pools there is a defined subpopula- 
tion of recently formed granules destined for preferential  re- 
lease instead of storage. 
It has recently been suggested that there are two pathways 
for the release of a secretory product (24), the so-called regu- 
lated and constitutive  pathways. For the regulated  pathway, 
a product is concentrated  into secretory granules which can 
accumulate in the cytoplasm and in which processing of any 
precursor can occur.  The granules  have a half-life of hours 
or days and the release of their products arises in response 
to a stimulus.  For the constitutive  pathway, newly synthe- 
sized products are packaged into membrane-limited  vesicles 
which, unlike secretory granules,  are destined for rapid re- 
lease in a nonregulated  fashion. There is only a short transit 
time between the Golgi complex and the plasma membrane, 
no cytoplasmic  storage pool, and no processing of precur- 
sors.  Since  some cells display both pathways for the same 
product (27, 41, 44) it is tempting to speculate that preferen- 
tial release of a newly synthesized  hormone involves com- 
mitment of some of this material to the constitutive pathway. 
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islets as a model system for studying the regulation of release 
of newly synthesized prohormone/hormone compared with 
that of a stored, processed hormone. There have been several 
previous studies showing the phenomenon of preferential re- 
lease of newly synthesized over stored insulin (6, 22,  38). 
However, these studies did not address the central issue of 
whether a portion of newly synthesized material was being 
directed to the putative constitutive pathway thereby explain- 
ing its rapid, preferential release. 
Materials and Methods 
Materials 
Male Sprague-Dawley rats (180-250 g) were purchased from Charles River 
Laboratories Inc., Wilmington, MA. L-[4,5-3H]leucine  (141-153 Ci/mmol) 
was obtained from Arnersham International, Amersham, Buckinghamshire, 
United Kingdom, and Bioeount scintillation cocktail from Research Prod- 
ucts International Corp., Mount Prospect, IL. Tissue culture medium TC 
199, RPMI 1640, and newborn calf serum were all from Irvine Scientific, 
Santa Ana, CA. Ficoll-400 was obtained from Pharmacia P. L. Biochemi- 
cals,  Uppsala, Sweden, and collngenase (type IV,  165  U/mg) was from 
Cooper Biomedical, Malvern, PA. All other chemicals were purchased from 
Fisher Scientific, Lexington, MA or Sigma Chemical Co., St. Louis, MO. 
Pancreatic Islet Isolation 
A modified procedure of Gotoh et al. (8) and Noel et al. (30) was followed 
for isolation of rat pancreatic islets. The pancreas of an anesthetized rat was 
distended via the pancreatic duct with 15 ml of TC 199 medium containing 
10 % vol/vol newborn calf serum and 1.5 mg/ml collagenase. The distended 
pancreas was then excised and digested at 37"C with shaking (100 strokes 
per min) for 20-30 rain, until an even, homogenous suspension of particu- 
late material was observed. The digest was washed three times with TC 
199/10% newborn calf serum and then filtered through a cellector (85 ml 
capacity, 40 mesh; Thomas Scientific, Swedesboro, NJ). The filtered tissue 
was then centrifuged (600 g for 5 rain), and the pellet resuspended in 23 % 
wt/vol Ficoll in TC 199 (no serum) in a 50-ml conical tube (0.5 mi tissue 
per 10 rnl Ficoll solution). This was then overlayered sequentially with 10 
ml of 20.5% and 5 ml each of 17 and 11% Ficoll in TC 199 (no serum) to 
form a discontinuous Ficoll gradient which was centrifuged for 20 min at 
800 g at 4°C (RT-6000 centrifuge, swinging head rotor; DuPont Co., Sor- 
vail Instrument Div., Newtown, CT). Isolated islets appear at the 20.5/17% 
interface of  the gradient and exocrine tissue pellets at the bottom of  the tube. 
The isolated islets were removed and washed three to four times in TC 
199/10% newborn calf serum. They were then maintained in RPMI 1640 
containing 8.3  mM  glucose,  10%  newborn calf serum,  penicillin (1(30 
U/ml), and streptomycin (0.1 mg/ml) for 48 h before use in subsequent ex- 
periments. Between 400 and 600 rat islets were routinely isolated per rat 
pancreas with this procedure. 
Pulse~Chase Radiolabeling of  Isolated Islets 
Approximately 2,000 isolated rat islets were taken after the 48-h tissue cul- 
ture period and washed in Krebs-Ringer bicarbonate buffer,  0.1%  wt/vol 
BSA, and 10 mM Hepes, pH 7.4 (KRB-BSA) with 2.8 mM glucose. At time 
zero, the islets were pulse-labeled at 3"/°C for 5 min in a 15-ml plastic coni- 
cal tube in  100  gl KRB-BSA containing 16.7 mM glucose and  1.0 mCi 
L-[4,5-3Hlleucine.  This  concentration of glucose was used to  stimulate 
proinsulin biosynthesis (42)  and thus to get maximum [3H]leucine  incor- 
poration into newly synthesized endogenous proinsulin during the 5-min 
radiolabeling period. Pulse-labeling of the islets was stopped by washing in 
ice-cold KRB-BSA, 2.8 mM glucose. The islets were split into two batches 
of 1,000 islets each in 3 ml KRB-BSA in 35  x  10-mm petri dishes (Falcon 
Labware, Oxnard, CA) for a 175-min postlabel (chase) incubation at 370C. 
The only difference between these two groups of islets was that one was at 
a glucose concentration for basal insulin release (2.8 raM) and the other at 
a stimulatory glucose concentration (16.7 mM) (see reference 18 for review). 
The period of pulse labeling was considered as time zero to 5 min, and the 
chase period a further 175 rain, for a total of 180 min. At the 15-, 30-, 45-, 
60-,  90-,  120-,  and  180-min  time points, a  200-gl  aliquot of the chase 
medium and 50 islets (in a 20-~tl aliquot) were removed from each of the 
two islet groups. After removal of the aliquot of medium it was centrifuged 
in a  1.5-ml microfuge tube (Bio-Rad Laboratories, Richmond, CA) at 800 
g for 10 rain (to pellet any cell debris). The pellet was discarded and the 
supernatant stored at -20°C pending analysis. The islets were washed once 
with 500 [tl ice-cold PBS containing 0.1% wt/vol BSA, pH 7.4 (PBS-BSA) 
by centrifugation (1500 g, 1 min, 1.5-ml plastic microfuge tube). The super- 
natant was removed and discarded, and the pelleted islets resuspended in 
100 gtl PBS-BSA. The islet aliquots were then sonicated (25 W,  10 s, soni- 
tier model B15-P;  Branson Sonic Power Co., Danbury, C-if), centrifuged 
(10,000 g, 2 min), and stored at  -20°C pending analysis. 
Analysis of  Islet Sonicates and Chase Medium 
The total immunoreactive insulin in the aliquots of chase medium and in 
the islet sonicate samples was assayed by radioirnmunoassay (19). 
The amount of [3H]proinsulin and [3H]insulin in the chase medium and 
islet sonicate samples was analyzed by HPLC (15). To compensate for the 
five leucine residues that are lost in rat C-peptides when rat proinsulins are 
converted to rat insulins, a correction factor of 11/6 was applied (13). The 
use of this HPLC technique was found to be quantitative in that in a given 
sample aliquot, the total radioactive counts recovered in the [3H]proinsulin 
and [3H]insniin peaks of an HPLC profile were equal (5:5%) to the radio- 
activity recovered by previously described quantitative anti-insulin immu- 
noprecipitation techniques (16, 17). Aliquots of  an islet sonicate or islet incu- 
bation medium were added directly  to  the  HPLC  system (model 332; 
Beckman Instruments, Inc., San Ramon, CA) without prior purification. An 
Altex Ultrasphere ODS 5 Ixm column (length, 25 cm; internal diameter, 
4.6 nun; Beckman Instruments, Inc., Altex Scientific Operations, Berkeley, 
CA) was used with the following buffers: (a) buffer A (TEAP): phosphoric 
acid (50 rnM), triethylamine (20 mM), sodium perehlorate (50 mM) ad- 
justed to pH 3.0 with sodium hydroxide; (b) buffer B: 90% vol/vol acetoni- 
trile, 10% vol/vol water. Both of  the rat insulins were eluted together isocrat- 
ically at 36% buffer B at a flow rate of 1 ml/min (12-13 min after the sample 
was injected into the system). At 20 rain the percentage of buffer B was in- 
creased linearly from 36 to 39% over 15 min and maintained at 39%  for 
an additional 25 rain, allowing for isocratic elution of both the rat proinsu- 
lins at 40 min after sample injection. The peaks were collected in 1-min frac- 
tions (1 ml vol) in tubes containing 100 ~tl of 0.5 mM sodium borate,  1% 
wt/vol BSA, pH 9.3, in order to have carder protein present and to neutralize 
the acidity of the elution buffer.  Radioactivity in the samples was detected 
by adding 10 ml of  Biocount scintillation cocktail to the fractions in scintilla- 
tion vials and by counting in a liquid scintillation counter (1215 Rackbeta 
II; LKB Instruments, Gaithersburg, MD) with 30-40 % counting efficiency. 
The [3I-I]leucine incorporation into total protein in aliqnots of islet soni- 
cates or chase medium was determined by precipitation with 10%  wt/vol 
TCA as previously described (2). The TCA precipitates were resuspended 
in 500 I.tl of I M acetic acid/1%  BSA, and transferred to scintillation vials. 
Then  10 ml of Biocount scintillation cocktail was added and the samples 
counted as previously described for HPLC fractions. 
Presentation of the Results 
All data are expressed as the mean +  SEM, with the number of independent 
observations indicated in parentheses or in the figure legends. The data are 
also corrected for the media removed for sampling during the course of the 
experiments. The level of significance for differences between groups was 
assessed by Student's t test for unpaired groups. 
Results 
The Release of Total Immunoreactive Insulin 
The total immunoreactive insulin released from islets with 
time at 2.8 mM or 16.7 mM glucose is shown in Fig.  1. At 
15 min, 16.7 mM glucose stimulated release of insulin four- 
fold (P <  0.001) above the basal release rate at 2.8 mM glu- 
cose. This stimulation increased to eightfold (P <  0.001) at 
180 min, at which time 15.7 +  1.3 % of the average islet insu- 
lin content (22.4  +  2.0 ng insulin/islet, n  =  48) had been 
released at 16.7 mM glucose compared with 1.8  +  0.3% at 
2.8 mM glucose. The average islet insulin content did not 
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Figure 1. The release of total stored immunoreactive insulin from 
isolated rat pancreatic  islets. Islets were chased for 175 min at 
2.8 mM glucose (solid circles) or 16.7 mM glucose (open circles) 
after a 5-rain pulse labeling period. The results are shown as a mean 
+  SEM of at least three individual observations. 
significantly alter at 2.8 or 16.7 mM glucose throughout the 
experiment. 
The Fate of  Newly Synthesized Proinsulin and 
Insulin during the Chase Period 
The fate of [3H]proinsulin during the chase period is shown 
in  Fig.  2.  There  was  no  detectable  newly  synthesized 
[3H]proinsulin released into the medium until the 45-min 
time point (Fig. 2, left). By 60 min, 0.47 -1- 0.04(3) % of the 
newly formed proinsulin had been released at basal, 2.8 mM, 
glucose and 0.46 +  0.05(3)% at 16.7 mM glucose. There was 
a  significant stimulation of [3H]proinsulin release by  16.7 
mM glucose from 90 min onwards (fourfold [P <  0.005] at 
90 min, rising to sixfold [P < 0.001] by 180 min). By 180 min, 
5.8  +  0.8(3) % of the initial islet pool of [3H]proinsulin had 
been released as  [3H]proinsulin when chased at  16.7 mM 
glucose, compared with 0.92 +  0.14(3)% at 2.8 mM glucose. 
The [3H]proinsulin that was retained in the islets (Fig.  2, 
right) decreased with time, reflecting both its release and the 
intracellular conversion of proinsulin to insulin and C-pep- 
tide (31, 42; also see Fig. 3 and 6) so that by 180 min only 
5.9 +  0.8(3)% (2.8 mM glucose) and 3.5 +  0.8(3)% (16.7 mM 
glucose)  of the  initial  islet  content of [3H]proinsulin  re- 
mained as the nonconverted prohormone. 
The fate of [3H]insulin  resulting from the conversion of 
[3H]proinsulin during the chase period is shown in Fig.  3. 
The data for [3H]insulin have been corrected for the loss of 
[3H]leucine associated with the conversion of proinsulin (11 
leucines) to insulin (6 leucines) and C-peptide (5 leucines) 
as described in Materials and Methods. There was no detect- 
able [3H]insulin  release into the medium until 60 min.  At 
90 min there was a ninefold stimulation (P < 0.005) of release 
of newly synthesized [3H]insulin  by 16.7 mM glucose com- 
pared with 2.8 mM glucose. This effect increased to an ll- 
fold stimulation (P < 0.001) by 180 min, resulting in 53.3  ___ 
3.5(3)%  of the initial islet content of [3H]proinsulin being 
released as [3H]insulin at 16.7 mM glucose and 4.8 +  0.6(3)% 
at 2.8 mM glucose (Fig. 3; left). 
The [3H]insulin  retained in the islets  (Fig.  3,  right)  in- 
creased during the early time points of the chase, reflecting 
its generation caused by the intracellular conversion of  proin- 
sulin to insulin and C-peptide (31, 42), which was mirrored 
by the  intracellular decrease in  [3H]proinsulin previously 
discussed (Figs.  2 and 5).  The intracellular [3H]insulin  in 
islets was first detectable at the 30-min time point, and be- 
tween 30 and 90 min there was no effect of glucose on its rate 
of appearance. At the later times, at 2.8 mM glucose, [3H]in- 
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Figure 2. The fate of newly synthesized [~H]proinsulin. Islets were chased for 175 min at 2.8 mM glucose (solid triangles) or 16.7 mM 
glucose (open triangles) after a 5-min pulse labeling period.  (Left) [3H]Proinsulin released into the medium; (right) [3H]proinsulin re- 
mined in the islets. The results are shown as a mean  +  SEM of at least three individual observations. 
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Figure 3. The fate of newly synthesized [3H]insulin.  Islets were chased for 175 min at 2.8 mM glucose (solid triangles) or 16.7 mM glu- 
cose (open triangles) after a 5-min pulse labeling period. (Left) [3H]Insulin  released into the medium; (right) [3H]insulin  retained in the 
islets.  The results are shown as a mean  +  SEM of at least three individual observations. The data have been corrected for the loss of 
[3H]leucine  residues associated with the conversion of proinsulin to insulin  and C-peptide (see Materials and Methods). 
sulin  in  islets  continued  to  increase,  resulting  in  83.5  + 
3.3(3) % of the original [3H]proinsulin synthesized being re- 
tained in the islets in the form of [3H]insulin at 180 min.  At 
16.7 mM glucose, there was a significant decrease in [3H]in- 
sulin retained in the islets compared with the 2.8 mM glucose 
chase.  Of the original [3H]proinsulin  synthesized only 53.4 
+  (3)%  at 120 min (P <  0.005) and 40.8  +  2.6(3)%  at 180 
min (P <  0.001)  was retained in islets as [3H]insulin (Fig.  3, 
right).  The  different  patterns  of islet  [3H]insulin  contents 
are an immediate result of glucose stimulation of [3H]insu- 
lin release during  the chase. 
The Preferential Release of Newly Synthesized 
Insulin during the Chase Period 
The highest specific radioactivity (expressed as disintegra- 
tions  per  minute  [3H]proinsulin  or  [3H]insulin  per  nano- 
gram  immunoreactive  insulin)  of  the  newly  synthesized 
[3H]proinsulin  in  the  islets  at  the  15-rain  time  point  was 
90.8  +  3.6(3)  and  90.9  +  5.8(3)  dpm/ng  for  islets  being 
chased  at  2.8  or  16.7 mM  glucose.  This  is  an  expected 
finding,  since, at this time, no newly synthesized proinsulin 
has been either  released or converted to insulin.  It should 
also be recalled that the islets used for the two chase condi- 
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Figure 4. The specific radioactivities of newly synthesized [3H]proinsulin  and [3H]insulin  released from isolated rat pancreatic islets.  Is- 
lets were chased for 175 min at 2.8 mM glucose (solid triangles) or 16.7 mM glucose (open triangles) after a 5-min pulse labeling period. 
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presented as in Fig. 3. 
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Figure 5.  The conversion of [3H]proinsulin (broken  line) to [3H]insulin (solid line)  in isolated rat pancreatic islets. Isolated islets were 
chased at either 2.8 mM (left) or 16.7 mM (right)  glucose after a 5-min pulse labeling period.  The results are presented as in Fig. 3. 
tions were obtained from the same common pool of 5-min 
pulse-labeled islets.  Any increase in specific radioactivity 
for material released during the chase compared with that of 
the islets at  15 rain indicates an isotopic enrichment and, 
thus, preferential release of newly synthesized hormone over 
that of the unlabeled stored hormone. 
The results for [3H]proinsulin (Fig. 4, left) must be con- 
sidered with caution.  The radioimmunoassay system used 
does not specifically discriminate between proinsulin and in- 
sulin, but the aftinity of the antibody towards proinsulin is 
only ,x,50% of that for insulin. The majority of the immuno- 
reactive material in islets and medium will, in addition, be 
insulin rather than proinsulin. The specific radioactivity for 
[aH]proinsulin  is  thus,  in  reality,  radioactivity measured 
specifically in proinsulin relative to immunoreactivity pre- 
dominantly arising from insulin. During the first 60 rain of 
the  chase  period,  there  was  only  a  small  amount  of 
[3H]proinsulin released (see Fig. 2), with no stimulation by 
glucose. From 60 min onward there was pronounced glucose 
stimulation. In contrast, immunoreactive insulin release was 
stimulated by glucose throughout the chase period (Fig.  1). 
The combined result of these observations is that there is no 
apparent isotopic enrichment of [3H]proinsulin in the chase 
medium (Fig. 4, left) and, indeed, the specific radioactivity 
at high glucose is lower than that at low glucose at the early 
time points. Without a specific radioimmunoassay for proin- 
sulin, however, it is not possible to determine whether newly 
synthesized proinsulin is released in preference to the very 
small amount of stored proinsulin. 
The  specific radioactivity of [3H]insulin  that  had  been 
released  into  the  medium  (Fig.  4,  center)  represents  a 
significant isotopic enrichment at the 120- (P < 0.01) and 180- 
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Figure 6.  The fate of newly synthesized PH] total protein (TCA precipitable) from isolated rat pancreatic islets. Islets were chased for 
175 rain at 2.8 mM glucose (solid triangles)  or 16.7 mM glucose (open triangles),  after a 5-min pulse labeling period. (Left) 3H total pro- 
tein released into the medium; (right) 3H total protein retained in the islets. The results are shown as a mean +  SEM of at least three 
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served in islets at 15 min at both basal (2.8 mM) and stimula- 
tory (16.7 mM) glucose chase concentrations. This suggests 
that during the later times of the chase period there was 
preferential release of newly Synthesized  [3H]insulin  rela- 
tive to that of stored (total immunoreactive) insulin irrespec- 
tive of the chase glucose concentration. When the specific 
radioactivities of released  [3H]proinsulin  and  [3H]insulin 
are considered together (Fig. 4, right), the isotopic enrich-  -'.~  o.~7~ 
ment is also observed from 90 min onwards (1.5-fold  in-  .~ 
crease). However, here again consideration should be given 
to the limited cross-reactivity of the immunoassay system for  z: 
proinsulin and insulin.  :~ 
<  The Conversion of  Proinsulin to Insulin during 
the Chase Periods at Different Glucose Concentrations 
When the amount of either [3H]proinsulin  or [3H]insulin in 
the islets and medium (Figs. 2 and 3) were combined at each 
time point during the chase period, an indication of intracel- 
lular [3H]proinsulin  conversion was obtained (Fig. 5). After 
an initial lag phase of '~,30 rain,  [3H]proinsulin  was con- 
verted with a half-time of  the order of  45-60 min irrespective 
of the ambient glucose concentration (compare both panels 
of Fig. 5). 
The Fate of Total Newly Synthesized Protein 
during the Chase Period 
The fate of newly synthesized 3H total protein (radioactivity 
precipitable with TCA) during the chase is shown in Fig. 6. 
Small quantities of 3H total protein could be found in the 
medium at 30 min (Fig. 6, left). There was no significant 
effect of 16.7 mM glucose on 3H total protein released be- 
tween 30  and 60  min compared with a  2.8-mM  glucose 
chase. However, the release of 3H total protein from 90 min 
onwards was stimulated by 3.5-fold  at 16.7 mM glucose (P 
< 0.01), so that by 180 min 19.1 +  2.5(3)% of the initial islet 
content of 3H total protein had been released at  16.7 mM 
glucose chase, and only 4.8 +  0.7(3)%  at 2.8 mM glucose. 
This was reflected in the 3H total protein retained in the is- 
lets by 180 min (79.9 _  1.013]  % at 16.7 mM glucose and 93.3 
+  7.2[3]%  at 2.8 mM glucose; Fig. 6, right). 
3H Total protein comprises both insulin-related and non- 
related material.  When the contribution of [3H]proinsulin 
and [3H]insulin  is discounted from the values for 3H total 
protein released during the chase period (Fig. 7) it is appar- 
ent that there was no significant effect of glucose on the re- 
lease of such non-insulin-related proteins. Furthermore, the 
quantity of such material released by 180 min amounted to 
<4%  of the  initial  islet  content of [3H]TCA-precipitable 
products. 
Discussion 
The Pathway of  Hormone Release 
The results described show that glucose-stimulated release 
of unlabeled  insulin stores  (immunoreactive insulin)  was 
similar to that previously observed (17, 21). This secretion 
pattern is, by definition, typical for a regulated pathway (24) 
in that the product is processed from a precursor (before its 
release) and is concentrated into secretory granules that ac- 
/// 
/// 
// 
/{ 
/ 
0 
0  30  60  90  120  180 
TIME  (mira] 
o~  L 
o 
Figure 7. The release of newly synthesized  3H total protein, other 
than  [3H]proinsulin and/or  l~H]insulin, from  isolated rat  pan- 
creatic islets. Islets were chased for 175 min at 2.8 mM glucose 
(solid triangles) or 16.7 mM glucose (open triangles), after a 5-min 
pulse labeling period. The results are shown as a mean + SEM of 
at least three individual observations. 
cumulate in the cytosol until their release is triggered by a 
stimulus (e.g., glucose in this particular instance). The pan- 
creatic B cell, therefore, represents a good model for regu- 
lated release of a stored hormone. 
Newly synthesized hormone or prohormone were only 
released from the B cells after an initial 45-min lag period. 
This lag period before release is due to the time required 
from synthesis on the rough endoplasmic reticulum to pas- 
sage through the Golgi complex, packaging into secretory 
granules, and transit to the plasma membrane for exocytosis 
(23, 31, 33).  The major component (90%) of newly synthe- 
sized products released to the medium was the processed 
hormone, insulin. The release of [3H]insulin  was glucose 
stimulated, suggesting its release via the regulated pathway. 
Even though the release of newly synthesized proinsulin was 
only a minor component of released newly synthesized prod- 
ucts  (10%),  the  majority of this  released  [3H]proinsulin 
(from 60 min onwards) was also subject to glucose regula- 
tion, and was therefore also presumed to be released via the 
regulated pathway. This confirms a previous observation that 
even when proinsulin conversion is inhibited its mode of re- 
lease appears unchanged (12). The small amount of newly 
synthesized proinsulin that was rapidly released between 30 
and 60 min, however, was not subject to glucose regulation 
and might therefore represent hormone that was released via 
the constitutive pathway (24).  Our data are also consistent 
with the presence of a constitutive release pathway active for 
non-insulin-related proteins synthesized in islet cells. 
Our results show that 99 % of newly synthesized proinsu- 
lin/insulin from pancreatic B cells is released via the regu- 
lated pathway and 1% is potentially released via the constitu- 
tive pathway. A single secretory cell product is usually only 
released via a constitutive or regulated pathway (9,  10, 24). 
However,  it has been suggested (from observations made 
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stances both constitutive and regulated pathways of release 
for one particular prohormone/hormone product may exist 
in the same cell (24, 27). Indeed, this has been suggested for 
insulin in virally transformed pancreatic B cells (HIT cell 
line [28]),  or B cell tumor-derived cells (5), where a much 
greater  proportion  of newly  synthesized proinsulin  was 
released via a  constitutive pathway than observed in this 
study. Similar observations have been made for ACTH re- 
lease from pituitary-derived AtT20 cells (27). When the hu- 
man insulin gene was transfected into AtT20 cells the subse- 
quently  synthesized proinsulin/insulin was  released  in  a 
fashion similar to that in HIT cells as, indeed, was the native 
hormone of AtT20 cells (ACTH) (28). It is possible that such 
observations of constitutive and regulated release for one 
product reflect the partial dedifferentiation of transformed 
cells  since  the  highly differentiated pancreatic  endocrine 
cells used in this study show prohormone/hormone release 
that appears to be mediated predominantly via the regulated 
pathway. 
The Preferential  Release of  Newly Synthesized Hormone 
The results show that from 85 min after the 5-min pulse-label 
period there was preferential release of newly synthesized 
proinsulin/insulin over that of stored insulin. Similar obser- 
vations have been made previously for insulin (6, 11, 22, 38) 
and also other hormones (3, 4, 20, 26, 35, 36, 40, 41, 43, 44, 
46, 47).  The present study does, however,  include two im- 
portant and novel observations. First, 99% of the released 
newly synthesized proinsulin/insulin was subjected to glu- 
cose regulation, and second, the major proportion (at least 
90 %) of the released newly synthesized hormone was in the 
form  of processed  [3H]insulin.  It  can  therefore be  con- 
cluded that preferential release of newly synthesized hor- 
mone is mediated via the regulated pathway only and is not 
a reflection of  constitutive release. Also, the specific radioac- 
tivities of  released newly synthesized insulin (and insulin and 
proinsulin  together)  indicate  that  preferential  release  of 
newly  synthesized  hormone  occurs  to  the  same  extent 
whether islets are incubated at basal or stimulatory glucose 
concentrations. Thus, even though there was elevated insulin 
release in glucose-stimulated islets, the proportion of newly 
synthesized hormone released relative to that of stored hor- 
mone was similar under basal or stimulatory conditions. 
Cellular heterogeneity has been proposed as a possible ex- 
planation for the preferential release of newly synthesized 
hormone (45).  Even though there is some evidence for islet 
B cell heterogeneity (37), it will be necessary to isolate and 
characterize the two putative B cell populations in order to 
establish whether such heterogeneity underlies preferential 
release of newly synthesized insulin. Our data would suggest 
that even a subpopulation of B cells displaying rapid insulin 
synthesis and release would still be operating almost entirely 
via the regulated release pathway. 
Two pools of secretory granules rather than two separate 
secretory pathways have also been suggested as a possible 
mechanism for the preferential release of newly synthesized 
hormone (11, 14, 26, 44).  According to these theories, the 
newly formed secretory granules compose a  granule pool 
that is more readily available for release than the pool of 
older stored granules.  Grodsky and co-workers have sug- 
gested that in the B cell glucose "marks" granules destined 
for preferential release during their production in the Golgi 
complex (5, 6).  Such granule heterogeneity generated by a 
stimulus signal has not been proposed for other secretory 
cell types and our present and previous (11) data do not sup- 
port this concept. In particular, we observe preferential re- 
lease of newly synthesized proinsulin/insulin even during a 
chase at basal 2.8-mM glucose. We therefore propose a new 
hypothesis to explain both our findings and those of others. 
This hypothesis is based on the present data as well as two 
other observations concerning the function of the B cell. (a) 
Exposure of B cells to glucose results in activation of the cell 
cytoskeleton by microfilament contraction and tubulin poly- 
merization leading to increased granule movement towards 
the plasma membrane and a consequent increase in exocyto- 
sis (21). (b) The Golgi complex of pancreatic B cells appears 
to be restricted to a specific intracellular location (25), which 
may suggest an association with the B cell cytoskeleton. In- 
deed, an association between microtubules and Golgi com- 
plex membrane has been shown in rat liver cells (1). 
We now propose that newly formed 13-granules, immedi- 
ately after budding off from the trans elements of the Golgi 
complex, become rapidly associated with the cytoskeleton 
or, alternatively, are already associated with it as they form. 
Older, stored 13-granules are less available for cytoskeleton 
attachment due to their more remote location in the cytosol. 
This more intimate association between new granules and 
the cytoskeleton  would result from apparent anchorage of the 
Golgi complex to the cytoskeleton, and would result in rapid 
exocytosis of such granules, thereby accounting for preferen- 
tial release of  newly formed proinsulirdinsulin. Glucose acti- 
vation of the  cytoskeleton, leading to  stimulated release, 
would, in our model, be as effective for any granule already 
associated with the cytoskeleton (i.e., new or old). Newly 
formed granules not released from the B cell would detach 
from the cytoskeleton  to become part of the stored pool. Glu- 
cose may play an additional role in stabilizing anchorage of 
granules to the cytoskeleton. It has been clearly shown that 
newly formed granules are characterized by a clathrin coat 
(so-called immature or coated granules; reference 31). It has 
furthermore been shown that proinsulin appears to be re- 
stricted to immature rather than mature granules (31, 32). 
The  immature  and  mature  granules,  with  their  different 
properties  and  contents,  could  have  represented  the  two 
pools of new and old granules. The immature coated granule 
may thus have been the substrate for rapid, possibly constitu- 
tive, release of newly formed proinsulin. Our data do not 
support this concept since glucose was found to regulate the 
release of newly synthesized proinsulin. We therefore sug- 
gest that, in terms of their secretory fate, new and old gran- 
ules are not handled differently. Preferential release simply 
reflects rapid association of new granules with the cytoskele- 
ton. Granule maturation (uncoating) and proinsulin conver- 
sion would arise in granules despite their association with 
the cytoskeleton. Thus, newly formed proinsulin and insulin 
would both be rapidly released and would both be sensitive 
to glucose stimulation. According to our model, the data of 
Gold et al. (5, 6) could be accounted for by a greater percent- 
age of newly formed granules being retained on the activated 
and more available cytoskeleton at high glucose (20, rather 
than by marking of the granules themselves. 
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The kinetics of proinsulin conversion shown in this study are 
in agreement with previous studies (31, 42). The rate and ex- 
tent of proinsulin conversion to insulin (and C-peptide) were 
similar  at basal  or stimulatory  concentrations of glucose. 
Since proinsulin cannot be converted to any significant extent 
once released from the B cell, the total extent of conversion 
reflects not only intrinsic B cell conversion activity per se but 
also the rate and extent of release of proinsulin from B cells 
(equivalent to its rate of escape from the conversion site), 
which was minimal even at 16.7 mM glucose. The apparent 
discrepancy between the results of those suggesting secreta- 
gogue regulation of proinsulin conversion (7,  29)  and our 
own data lies in a fundamental difference in experimental de- 
sign. Thus, Nagamatsu et al (29) found that after prolonged 
exposure of islets to glucose there was an acceleration in the 
subsequent conversion of proinsulin to insulin. Their data 
support our conclusion that glucose has no effect on conver- 
sion of preformed proinsulin after an acute exposure of islets 
to the sugar. 
Conclusion 
Taken  together, our data show that in a highly specialized 
secretory cell,  such as the pancreatic B cell,  the release of 
the major secretory products occurs via a regulated pathway. 
This applies to both proinsulin and insulin. The preferential 
release of newly synthesized proinsulin/insulin occurs to the 
same extent at both stimulatory and nonstimulatory glucose 
concentrations. Although the precise mechanism responsi- 
ble  for preferential  release  of newly  synthesized proinsu- 
lin/insulin remains  to be determined,  we  suggest  that the 
preferential association of newly formed granules with the 
cytoskeleton may explain this phenomenon. Our data do not 
exclude the existence of a constitutive release pathway in islet 
cells.  Indeed, non-insulin-related proteins would appear to 
be released via such a pathway, albeit to a limited extent. For 
proinsulin and insulin, however, the contribution of a consti- 
tutive routing is indeed small, accounting for <1% of newly 
synthesized proinsulin or insulin released from the B cell. It 
is, finally, possible that in transformed cells (i.e.,  secretory 
cell lines) there is a shift from the regulated to the constitu- 
tive pathway resulting in a more pronounced nonregulated 
secretion of prohormone. 
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